Abstract:Abstract Glioma is an extremely aggressive malignant neoplasm of the central nervous system. MicroRNA (miRNA) are known to bind to specific target mRNA to regulate post-transcriptional gene expression and are, therefore, currently regarded as promising biomarkers for glioma diagnosis and prognosis. The aim of the present study was to examine the pathogenesis and potential molecular markers of glioma by comparing the differential expression of miRNA and mRNA between glioma tissue and peritumor brain tissue. We explored the impact of screened core miRNA and mRNA on cell proliferation, invasion, and migration of glioma. An miRNA expression profile dataset (GSE90603) and a transcriptome profile dataset (GSE90598) were downloaded from combined miRNA-mRNA microarray chips in the Gene Expression Omnibus (GEO) database. Overall, 59 differentially expressed miRNAs (DEMs) and 419 differentially expressed genes (DEGs) were identified using the R limma software package. FunRich software was used to predict DEM target genes and miRNA-gene pairs, and Perl software was used to find overlapping genes between DEGs and DEM target genes. There were 129 overlapping genes regulated by nine miRNAs between target genes of the DEMs and DEGs. The Chinese Glioma Genome Atlas(CGGA) was analyzed in order to identify miRNAs with diagnostic and prognostic significance. MiR-139-5p, miR-137, and miR-338-3p were validated to be significantly linked to prognosis in glioma patients. Finally, we validated that miR-139-5p affected glioma malignant biological behavior via targeting gamma-aminobutyric acid A receptor alpha 1(GABRA1) through rescue experiments. Low miR-139-5p expression was correlated with survival probability and World Health Organization (WHO) grade. MiR-139-5p overexpression inhibited cell proliferation, migration, and invasion of glioma in vitro. GABRA1 was identified as a functional downstream target of miR-139-5p. Decreased GABRA1 expression was related to similar biological roles as miR-139-5p overexpression while upregulation of GABRA1 effectively reversed the inhibition effects of miR-139-5p. These results demonstrate a novel axis for miR-139-5p/GABRA1 in glioma progression and provide potential prognostic predictors and therapeutic target for glioma patients.

Mir-7 Inhibits Glioblastoma Growth by Simultaneously Interfering with the PI3K/ATK and Raf/MEK/ERK Pathways.

Mir-27a Regulates Wnt/Beta-Catenin Signaling Through Targeting Sfrp1 in Glioma

MiR-7-5p is Frequently Downregulated in Glioblastoma Microvasculature and Inhibits Vascular Endothelial Cell Proliferation by Targeting RAF1

Regulation Of Epidermal Growth Factor Receptor Signaling By Plasmid-Based Microrna-7 Inhibits Human Malignant Gliomas Growth And Metastasis In Vivo

Mir-138-5p Suppresses Glioblastoma Cell Viability and Leads to Cell Cycle Arrest by Targeting Cyclin D3.

The Effect Of Mir-7 On Behavior And Global Protein Expression In Glioma Cell Lines

Mir-30a-5p Antisense Oligonucleotide Suppresses Glioma Cell Growth by Targeting Sept7

MicroRNA-137 inhibits growth of glioblastoma through EGFR suppression.

MiR-137 targets and regulates E2F7 to suppress progression of glioma cells

miR-7 inhibits the invasion and metastasis of gastric cancer cells by suppressing epidermal growth factor receptor expression.

miR-708 acts as a tumor suppressor in human glioblastoma cells.

MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma.

Mir-433 Inhibits Glioblastoma Progression by Suppressing the PI3K/Akt Signaling Pathway Through Direct Targeting of ERBB4

MiR-483-5p suppresses the proliferation of glioma cells via directly targeting ERK1.

Mir-494-3p Regulates Cellular Proliferation, Invasion, Migration, and Apoptosis by PTEN/AKT Signaling in Human Glioblastoma Cells

Mir-577 Inhibits Glioblastoma Tumor Growth Via the Wnt Signaling Pathway

MicroRNA-7 inhibits tumor metastasis and reverses epithelial-mesenchymal transition through AKT/ERK1/2 inactivation by targeting EGFR in epithelial ovarian cancer.

Microrna-1471 Suppresses Glioma Cell Growth and Invasion by Repressing Metadherin Expression.

Mir-508-5p Inhibits the Progression of Glioma by Targeting Glycoprotein Non-Metastatic Melanoma B

Mir-139-5p inhibits glioma cell proliferation and progression by targeting GABRA1

MicroRNA-127-3p promotes glioblastoma cell migration and invasion by targeting the tumor-suppressor gene SEPT7.